Clonal evolution in therapy-related neoplasms-Reference-Cited by-同舟云学术

Clonal evolution in therapy-related neoplasms

Published:2017-01-05 Issue:7 Volume:8 Page:12031-12040
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Fabiani Emiliano¹²,Falconi Giulia¹²,Fianchi Luana²,Criscuolo Marianna²,Ottone Tiziana¹,Cicconi Laura¹,Hohaus Stefan²,Sica Simona²,Postorino Massimiliano¹,Neri Antonino³,Lionetti Marta³,Leone Giuseppe²,Lo-Coco Francesco¹,Voso Maria Teresa¹

Affiliation:

1. Department of Biomedicine and Prevention, Universita’ Tor Vergata, Rome, Italy

2. Department of Hematology, Universita’ Cattolica S. Cuore, Rome, Italy

3. Department of Clinical Sciences and Community Health, Università degli studi di Milano, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of clonal progression leading to the development of therapy-related myeloid neoplasms;Annals of Hematology;2024-07-20

2. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt;Cancer;2024-01-20

3. THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION;Mediterranean Journal of Hematology and Infectious Diseases;2023-10-30

4. BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS;Mediterranean Journal of Hematology and Infectious Diseases;2023-08-29

5. The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells;Biochemical Pharmacology;2023-08